Being familiar with how AB-PINACA interacts with cannabinoid receptors can offer insights into prospective therapeutic applications and the mechanisms of cannabinoid-related Diseases.AB-PINACA is classed being a artificial cannabinoid receptor agonist, that means it binds to CB1 and CB2 receptors to mimic the effects of purely natural cannabinoids